Voya Investment Management LLC Cuts Stake in HCA Healthcare, Inc. $HCA

Key Points

• Voya Investment Management LLC reduced its stake in HCA Healthcare by 1.4%, now owning 77,672 shares valued at approximately $26.84 million.
• HCA Healthcare reported a quarterly EPS of $6.84, exceeding estimates by $0.64, with revenues reaching $18.61 billion, a 6.4% year-over-year increase.
• The company announced a quarterly dividend of $0.72 per share, equating to an annualized dividend yield of 0.7%, set to be paid on September 30th.

Voya Investment Management LLC trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 77,672 shares of the company's stock after selling 1,103 shares during the period. Voya Investment Management LLC's holdings in HCA Healthcare were worth $26,840,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cheviot Value Management LLC purchased a new position in HCA Healthcare during the first quarter valued at $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare in the first quarter worth about $26,000. WPG Advisers LLC purchased a new position in shares of HCA Healthcare in the first quarter worth about $27,000. Atwood & Palmer Inc. acquired a new stake in HCA Healthcare during the first quarter worth about $28,000. Finally, Bartlett & CO. Wealth Management LLC increased its position in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HCA. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research report on Thursday, August 14th. Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Robert W. Baird boosted their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $407.75.

HCA Healthcare Stock Up 0.2%

Shares of HCA Healthcare stock traded up $1.00 during trading hours on Friday, hitting $402.06. The company had a trading volume of 4,308,470 shares, compared to its average volume of 1,077,287. The company's 50-day moving average is $385.21 and its two-hundred day moving average is $365.77. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $420.98. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company has a market cap of $94.08 billion, a P/E ratio of 16.90, a price-to-earnings-growth ratio of 1.26 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the prior year, the firm earned $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio is 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.